SELENOP and Cognitive impairment: We found that relatively high CSF selenoprotein P concentrations characterized both prevalent AD and the milder degree of cognitive impairment represented by MCI, while in spline and logistic regression analysis, there was a stronger and monotonic association with AD risk compared with the inconsistent relation with MCI risk.